OptimizeRx to Participate at Bank of America Merrill Lynch Health Care Conference on May 13, 2020
The event is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community.
He will also share insight on the company’s latest acquisition of a powerful digital therapeutics SaaS platform,
The live presentation will be available at investors.optimizerx.com/events-and-presentations.
The event is for institutional clients of BOA and is by invitation only. To schedule a one-on-one meeting with
Important Cautions Regarding Forward Looking Statements
This press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended, and such as in section 21E of the Securities Act of 1934, as amended. These forward-looking statements should not be used to make an investment decision. The words 'estimate,' 'possible' and 'seeking' and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition, and other material risks.
Tel (248) 651-6568 x807
Media Relations Contact
Tel (754) 245-7070
Investor Relations Contact
CMA Investor Relations
Tel (949) 432-7557
Source: OptimizeRx Corporation